Related references
Note: Only part of the references are listed.Small Molecular Compounds that Inhibit Hepatitis C Virus Replication Through Destabilizing Heat Shock Cognate 70 Messenger RNA
Zong-Gen Peng et al.
HEPATOLOGY (2010)
Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G
Shan Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
Jean-Pierre Vartanian et al.
PLOS PATHOGENS (2010)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
Sequence variation of NS3 and NS4A in hepatitis C virus (HCV) replicons following exposure to ITMN-191 concentrations likely to encompass those achieved in human liver following clinical dosing
A. J. V. Thompson et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification of HCV protease inhibitor resistance mutations by selection pressure-based method
Ping Qiu et al.
NUCLEIC ACIDS RESEARCH (2009)
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity
Eva-K Pauli et al.
RETROVIROLOGY (2009)
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Inigo Narvaiza et al.
PLOS PATHOGENS (2009)
Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients
Thomas Kuntzen et al.
HEPATOLOGY (2008)
Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H
Josef Koeck et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Small-molecule inhibition of HIV-1 Vif
Robin Nathans et al.
NATURE BIOTECHNOLOGY (2008)
Enhancing immunity to HIV through APOBEC
Reuben Harris
NATURE BIOTECHNOLOGY (2008)
Hepatitis C therapies
Irena Melnikova
NATURE REVIEWS DRUG DISCOVERY (2008)
Interferon-based therapy for chronic hepatitis C: current and future perspectives
Stefan Zeuzem
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
Viral hepatitis in HIV infection
Margaret James Koziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
APOBEC-mediated viral restriction: not simply editing?
Rebecca K. Holmes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv
Fei Guo et al.
JOURNAL OF VIROLOGY (2006)
High expression of APOBEC3G in patients infected with hepatitis C virus
Yoshihiro Komohara et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates
Veronique Zennou et al.
VIROLOGY (2006)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
APOBEC3G targets human T-cell leukemia virus type 1
A Sasada et al.
RETROVIROLOGY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Recovery of APOBEC3-edited human immunodeficiency virus G -> A hypermutants by differential DNA denaturation PCR
R Suspene et al.
JOURNAL OF GENERAL VIROLOGY (2005)
The interaction between HIV-1 Gag and APOBEC3G
S Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity
S Kao et al.
JOURNAL OF VIROLOGY (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Real-time RT-PCR for quantitation of hepatitis C virus RNA
JH Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22
A Jarmuz et al.
GENOMICS (2002)
Share Paper
